Proteome Sciences PLC Result of AGM
16 Mai 2024 - 2:10PM
RNS Regulatory News
RNS Number : 7666O
Proteome Sciences PLC
16 May 2024
16 May
2024
Proteome Sciences
plc
("Proteome Sciences" or the
"Company")
Result of Annual General
Meeting (AGM)
The directors of Proteome Sciences
are pleased to announce that at the Company's AGM, held at
12.00 noon today, all resolutions were duly passed.
|
Proteome Sciences plc
|
|
Dr. Mariola Soehngen, Chief
Executive Officer
Dr. Ian Pike, Chief Scientific
Officer
|
Tel: +44 (0)20 7043 2116
|
|
|
Richard Dennis, Chief Commercial
Officer
Abdelghani Omari, Chief Financial
Officer
|
|
|
|
|
|
|
|
Allenby Capital Limited (Nominated Adviser &
Broker)
|
|
|
John Depasquale / Lauren Wright
(Corporate Finance)
Tony Quirke / Stefano Aquilino
(Equity Sales & Corporate Broking)
|
Tel: +44 (0) 20 3328 5656
|
|
|
|
About Proteome Sciences plc. (www.proteomics.com)
Proteome Sciences plc is a
specialist provider of contract proteomics services to enable drug
discovery, development and biomarker identification, and employs
proprietary workflows for the optimum analysis of tissues, cells
and body fluids. SysQuant® and TMT®MS2 are unbiased methods for
identifying and contextualising new targets and defining mechanisms
of biological activity, while analysis using Super-Depletion and
TMTcalibrator™ provides access to over 8,500 circulating plasma
proteins for the discovery of disease-related biomarkers. Targeted
assay development using mass spectrometry delivers high
sensitivity, interference-free biomarker analyses in situations
where standard ELISA assays are not available.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
RAGAFMTTMTMBBJI
Proteome Sciences (LSE:PRM)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Proteome Sciences (LSE:PRM)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
